Metformin treatment in Africa- META
- https://www.ucl.ac.uk/global-health/research/z-research/respond-africa/metformin-treatment-africa-meta
- https://www.inteafrica.org/related-projects/meta-trial/
- https://www.lstmed.ac.uk/research/departments/international-public-health/respond-africa/meta
- http://www.isrctn.com/ISRCTN76157257
py 3.12 / DJ 5.1 / edc 0.6.0 (META3)
This codebase is used for two randomized clinical trials:
META PHASE II:
(final version 0.1.77)
Metformin Treatment for Diabetes Prevention in Africa: META Trial TASO, MRC/UVRI/LSHTM, NIMR – TZ and Liverpool School of Tropical Medicine (ISRCTN76157257) http://www.isrctn.com/ISRCTN76157257
META PHASE III:
A randomised placebo-controlled double-blind phase III trial to determine the effects of metformin versus placebo on the incidence of diabetes in HIV-infected persons with pre-diabetes in Tanzania.
Liverpool School of Tropical Medicine
EDCTP grant number: RIA2018CO-2513
Trial registration: ISCRTN 77382043
https://ico.org.uk/ESDWebPages/Entry/Z4763134
See also https://github.com/clinicedc/edc
To setup a demo system, see https://github.com/meta-trial/meta3-sample